Market Forecast by Countries (Brazil, Mexico, Argentina, Rest of Latin America), By Drug Category (Antiemetic, Acid Neutralizers, Anti-inflammatory, Laxatives & Antidiarrheal, Others), By Route of Administration (Oral, Parenteral, Rectal), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), By Disease Types (Inflammatory Bowel Diseases, Gastroesophageal Reflux Diseases, Others) And Competitive Landscape
Product Code: ETC059106 | Publication Date: Mar 2023 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
The Latin America Gastrointestinal Drugs Market is anticipated to progress more during the forecast period owing to the rising prevalence of chronic digestive diseases as well as the rising adoption of advanced technologies like endoscopy as well as X-ray machines.
According to 6Wresearch, the Latin America Gastrointestinal Drugs Market size is anticipated to grow at a higher growth rate during 2023-2029. The sector in the region has been attaining popularity since the time it started operating. Factors such as the rising prevalence of chronic digestive diseases as well as the rising adoption of advanced technologies like endoscopy as well as X-ray machines have been driving the sector in the country. The pharmaceutical sector is projected to lead the Latin America Gastrointestinal Drugs Industry owing to its strong revenue generation capabilities, supported by high demand for hospitals as well as pharmacies.
There are many major companies operating in the industry and it is with their efforts that the market has been gaining continuous growth across the region. The competition in the sector is rising with each passing day due to the way the market works. The future of this market looks promising as the Latin America Gastrointestinal Drugs Market share is constantly growing.
The pandemic had a major impact on the Gastrointestinal Drugs Market in Latin America. The pandemic completely disrupted supply chains, affected demand, as well as caused major economic as well as social upheaval in the continent.
One of the key impacts of the COVID-19 pandemic was on the supply chain of pharmaceutical items, including gastrointestinal drugs. Restrictions on the movement of people in the continent and lockdown during the pandemic affected the production as well as distribution of these drugs. In addition, disruptions to international trade resulted in a lack of key raw materials, which further impacted drug production in the region.
The pandemic also affected the demand for gastrointestinal drugs in the region. While the prevalence of gastrointestinal disorders remained consistent, the pandemic led to transformations in health-seeking behaviour. Patients were less likely to seek medical attention including gastrointestinal disorders, owing to concerns about exposure to the virus. This resulted in lower demand for gastrointestinal drugs in the continent.
Moreover, the economic impact of the coronavirus pandemic also affected the sector. The economic downturn resulted in decreased spending on healthcare, which further impacted the demand for drugs. In addition, governments had to redirect resources towards arranging the pandemic, which resulted in lower funding for pharmaceuticals and healthcare.
Based on countries, the sector is fragmented into Brazil, Mexico, Argentina, and the Rest Of Latin America. The demand for gastrointestinal drugs is rising in every country in the region.
Based on the drug category, the industry is fragmented into Antiemetic, Acid Neutralizers, Anti-Inflammatory, Laxatives & Antidiarrheal, and Others. All these drug categories are projected to grow in the coming years.
Market Analysis by Route Of Administration
Based on the route of administration, the sector is fragmented into Oral, Parenteral, and Rectal. The oral segment held the largest share in the sector and it is projected to account for the largest market share.
Based on distribution channels, the market is divided into Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies. Online Pharmacies are likely to grow in the market.
Based on disease types, the industry is divided into Inflammatory Bowel Diseases, Gastroesophageal Reflux Diseases, and Others. All these disease types stimulate the demand for gastrointestinal drugs.
The report offers a comprehensive study of the subsequent market segments:
1. What is the future of the Latin America Gastrointestinal Drugs Market?
The Latin America Gastrointestinal Drugs Market is anticipated to progress more during the forecast period owing to the rising prevalence of chronic digestive diseases as well as the rising adoption of advanced technologies like endoscopy as well as X-ray machines.
2. Is there high competition in the market?
There are many major companies operating in the industry and it is with their efforts that the market has been gaining continuous growth across the region. The competition in the sector is rising with each passing day due to the way the market works.
3. What are the factors contributing to the market growth?
The rising prevalence of chronic digestive diseases as well as the rising adoption of advanced technologies like endoscopy as well as X-ray machines are the factors stimulating the sector's growth.
4. Which sector in the region is likely to lead the Latin America Gastrointestinal Drugs Market?
The pharmaceutical sector is projected to lead the Latin America Gastrointestinal Drugs Industry owing to its strong revenue generation capabilities, supported by high demand for hospitals as well as pharmacies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latin America Gastrointestinal Drugs Market Overview |
3.1 Latin America Regional Macro Economic Indicators |
3.2 Latin America Gastrointestinal Drugs Market Revenues & Volume, 2022 - 2029F |
3.3 Latin America Gastrointestinal Drugs Market - Industry Life Cycle |
3.4 Latin America Gastrointestinal Drugs Market - Porter's Five Forces |
3.5 Latin America Gastrointestinal Drugs Market Revenues & Volume Share, By Countries, 2022 - 2029F |
3.6 Latin America Gastrointestinal Drugs Market Revenues & Volume Share, By Drug Category, 2022 - 2029F |
3.7 Latin America Gastrointestinal Drugs Market Revenues & Volume Share, By Route of Administration, 2022 - 2029F |
3.8 Latin America Gastrointestinal Drugs Market Revenues & Volume Share, By Distribution Channel, 2022 - 2029F |
3.9 Latin America Gastrointestinal Drugs Market Revenues & Volume Share, By Disease Types, 2022 - 2029F |
4 Latin America Gastrointestinal Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latin America Gastrointestinal Drugs Market Trends |
6 Latin America Gastrointestinal Drugs Market, 2019 - 2029 |
6.1 Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2019 - 2029 |
6.2 Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2019 - 2029 |
6.3 Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2019 - 2029 |
6.4 Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2019 - 2029 |
7 Brazil Gastrointestinal Drugs Market, 2019 - 2029 |
7.1 Brazil Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2019 - 2029 |
7.2 Brazil Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2019 - 2029 |
7.3 Brazil Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2019 - 2029 |
7.4 Brazil Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2019 - 2029 |
8 Mexico Gastrointestinal Drugs Market, 2019 - 2029 |
8.1 Mexico Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2019 - 2029 |
8.2 Mexico Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2019 - 2029 |
8.3 Mexico Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2019 - 2029 |
8.4 Mexico Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2019 - 2029 |
9 Argentina Gastrointestinal Drugs Market, 2019 - 2029 |
9.1 Argentina Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2019 - 2029 |
9.2 Argentina Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2019 - 2029 |
9.3 Argentina Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2019 - 2029 |
9.4 Argentina Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2019 - 2029 |
10 Rest of Latin America Gastrointestinal Drugs Market, 2019 - 2029 |
10.1 Rest of Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Drug Category, 2019 - 2029 |
10.2 Rest of Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Route of Administration, 2019 - 2029 |
10.3 Rest of Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Distribution Channel, 2019 - 2029 |
10.4 Rest of Latin America Gastrointestinal Drugs Market, Revenues & Volume, By Disease Types, 2019 - 2029 |
11 Latin America Gastrointestinal Drugs Market Key Performance Indicators |
12 Latin America Gastrointestinal Drugs Market - Opportunity Assessment |
12.1 Latin America Gastrointestinal Drugs Market Opportunity Assessment, By Countries, 2022 - 2029F |
12.2 Latin America Gastrointestinal Drugs Market Opportunity Assessment, By Drug Category, 2022 - 2029F |
12.3 Latin America Gastrointestinal Drugs Market Opportunity Assessment, By Route of Administration, 2022 - 2029F |
12.4 Latin America Gastrointestinal Drugs Market Opportunity Assessment, By Distribution Channel, 2022 - 2029F |
12.5 Latin America Gastrointestinal Drugs Market Opportunity Assessment, By Disease Types, 2022 - 2029F |
13 Latin America Gastrointestinal Drugs Market - Competitive Landscape |
13.1 Latin America Gastrointestinal Drugs Market Revenue Share, By Companies, 2022 |
13.2 Latin America Gastrointestinal Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
14 Company Profiles |
15 Recommendations |
16 Disclaimer |